AI-Enabled听Imaging听Modalities help to automate and standardize not only workflows but also complex diagnostics to meet the needs of the individual patient. AI-Enabled听Imaging听Modalities develop with a kind of specific advanced algorithm to improve the accuracy of diagnosis and reduce the time required for diagnosis, helping doctors interpret chest radiographs.
麻豆原创 Analysis and Insights: Global AI-Enabled Imaging Modalities 麻豆原创
The global AI-Enabled Imaging Modalities market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Food听Safety听Testing听Systems听and听Services are the combination of the products and service provided to prevent food poisoning outbreaks and so the food needs to be tested under normal conditions. To conduct this analysis you would ship a sample of your food product to us and we will perform the test.
Report Includes
This report presents an overview of global market for AI-Enabled Imaging Modalities market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of AI-Enabled Imaging Modalities, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for AI-Enabled Imaging Modalities, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI-Enabled Imaging Modalities revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global AI-Enabled Imaging Modalities market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for AI-Enabled Imaging Modalities revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Koninklijke Philips N.V., Siemens Healthineers AG., General Electric Company, Canon, Inc., Agfa, Hologic, Fujifilm, Konica Minolta, Inc. and United Health Imaging, etc.
By Company
Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon, Inc.
Agfa
Hologic
Fujifilm
Konica Minolta, Inc.
United Health Imaging
Exo
Nanox
Butterfly Network, Inc.
Hyperfine
Segment by Type
Computed Tomography (CT)
MRI
X-Ray
Ultrasound
Positron Emission Tomography (PET)
Other Modalities
Segment by Application
Cardiology
Oncology
Neurology
Pulmonology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of AI-Enabled Imaging Modalities in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-Enabled Imaging Modalities companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Enabled Imaging Modalities revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global AI-Enabled Imaging Modalities 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Computed Tomography (CT)
1.2.3 MRI
1.2.4 X-Ray
1.2.5 Ultrasound
1.2.6 Positron Emission Tomography (PET)
1.2.7 Other Modalities
1.3 麻豆原创 by Application
1.3.1 Global AI-Enabled Imaging Modalities 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Pulmonology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-Enabled Imaging Modalities 麻豆原创 Perspective (2018-2029)
2.2 Global AI-Enabled Imaging Modalities Growth Trends by Region
2.2.1 AI-Enabled Imaging Modalities 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI-Enabled Imaging Modalities Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 AI-Enabled Imaging Modalities Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 AI-Enabled Imaging Modalities 麻豆原创 Dynamics
2.3.1 AI-Enabled Imaging Modalities Industry Trends
2.3.2 AI-Enabled Imaging Modalities 麻豆原创 Drivers
2.3.3 AI-Enabled Imaging Modalities 麻豆原创 Challenges
2.3.4 AI-Enabled Imaging Modalities 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue AI-Enabled Imaging Modalities by Players
3.1.1 Global AI-Enabled Imaging Modalities Revenue by Players (2018-2023)
3.1.2 Global AI-Enabled Imaging Modalities Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global AI-Enabled Imaging Modalities 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of AI-Enabled Imaging Modalities, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global AI-Enabled Imaging Modalities 麻豆原创 Concentration Ratio
3.4.1 Global AI-Enabled Imaging Modalities 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-Enabled Imaging Modalities Revenue in 2022
3.5 Global Key Players of AI-Enabled Imaging Modalities Head office and Area Served
3.6 Global Key Players of AI-Enabled Imaging Modalities, Product and Application
3.7 Global Key Players of AI-Enabled Imaging Modalities, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-Enabled Imaging Modalities Breakdown Data by Type
4.1 Global AI-Enabled Imaging Modalities Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global AI-Enabled Imaging Modalities Forecasted 麻豆原创 Size by Type (2024-2029)
5 AI-Enabled Imaging Modalities Breakdown Data by Application
5.1 Global AI-Enabled Imaging Modalities Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global AI-Enabled Imaging Modalities Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America AI-Enabled Imaging Modalities 麻豆原创 Size (2018-2029)
6.2 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Type
6.2.1 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2018-2023)
6.2.2 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2024-2029)
6.2.3 North America AI-Enabled Imaging Modalities 麻豆原创 Share by Type (2018-2029)
6.3 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Application
6.3.1 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2018-2023)
6.3.2 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2024-2029)
6.3.3 North America AI-Enabled Imaging Modalities 麻豆原创 Share by Application (2018-2029)
6.4 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Country
6.4.1 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2018-2023)
6.4.3 North America AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe AI-Enabled Imaging Modalities 麻豆原创 Size (2018-2029)
7.2 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Type
7.2.1 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe AI-Enabled Imaging Modalities 麻豆原创 Share by Type (2018-2029)
7.3 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Application
7.3.1 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe AI-Enabled Imaging Modalities 麻豆原创 Share by Application (2018-2029)
7.4 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Country
7.4.1 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China AI-Enabled Imaging Modalities 麻豆原创 Size (2018-2029)
8.2 China AI-Enabled Imaging Modalities 麻豆原创 Size by Type
8.2.1 China AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2018-2023)
8.2.2 China AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2024-2029)
8.2.3 China AI-Enabled Imaging Modalities 麻豆原创 Share by Type (2018-2029)
8.3 China AI-Enabled Imaging Modalities 麻豆原创 Size by Application
8.3.1 China AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2018-2023)
8.3.2 China AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2024-2029)
8.3.3 China AI-Enabled Imaging Modalities 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia AI-Enabled Imaging Modalities 麻豆原创 Size (2018-2029)
9.2 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Type
9.2.1 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia AI-Enabled Imaging Modalities 麻豆原创 Share by Type (2018-2029)
9.3 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Application
9.3.1 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia AI-Enabled Imaging Modalities 麻豆原创 Share by Application (2018-2029)
9.4 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Region
9.4.1 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia AI-Enabled Imaging Modalities 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America AI-Enabled Imaging Modalities 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Koninklijke Philips N.V.
11.1.1 Koninklijke Philips N.V. Company Details
11.1.2 Koninklijke Philips N.V. Business Overview
11.1.3 Koninklijke Philips N.V. AI-Enabled Imaging Modalities Introduction
11.1.4 Koninklijke Philips N.V. Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.1.5 Koninklijke Philips N.V. Recent Developments
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Company Details
11.2.2 Siemens Healthineers AG. Business Overview
11.2.3 Siemens Healthineers AG. AI-Enabled Imaging Modalities Introduction
11.2.4 Siemens Healthineers AG. Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.2.5 Siemens Healthineers AG. Recent Developments
11.3 General Electric Company
11.3.1 General Electric Company Company Details
11.3.2 General Electric Company Business Overview
11.3.3 General Electric Company AI-Enabled Imaging Modalities Introduction
11.3.4 General Electric Company Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.3.5 General Electric Company Recent Developments
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Details
11.4.2 Canon, Inc. Business Overview
11.4.3 Canon, Inc. AI-Enabled Imaging Modalities Introduction
11.4.4 Canon, Inc. Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.4.5 Canon, Inc. Recent Developments
11.5 Agfa
11.5.1 Agfa Company Details
11.5.2 Agfa Business Overview
11.5.3 Agfa AI-Enabled Imaging Modalities Introduction
11.5.4 Agfa Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.5.5 Agfa Recent Developments
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic AI-Enabled Imaging Modalities Introduction
11.6.4 Hologic Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.6.5 Hologic Recent Developments
11.7 Fujifilm
11.7.1 Fujifilm Company Details
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm AI-Enabled Imaging Modalities Introduction
11.7.4 Fujifilm Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.7.5 Fujifilm Recent Developments
11.8 Konica Minolta, Inc.
11.8.1 Konica Minolta, Inc. Company Details
11.8.2 Konica Minolta, Inc. Business Overview
11.8.3 Konica Minolta, Inc. AI-Enabled Imaging Modalities Introduction
11.8.4 Konica Minolta, Inc. Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.8.5 Konica Minolta, Inc. Recent Developments
11.9 United Health Imaging
11.9.1 United Health Imaging Company Details
11.9.2 United Health Imaging Business Overview
11.9.3 United Health Imaging AI-Enabled Imaging Modalities Introduction
11.9.4 United Health Imaging Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.9.5 United Health Imaging Recent Developments
11.10 Exo
11.10.1 Exo Company Details
11.10.2 Exo Business Overview
11.10.3 Exo AI-Enabled Imaging Modalities Introduction
11.10.4 Exo Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.10.5 Exo Recent Developments
11.11 Nanox
11.11.1 Nanox Company Details
11.11.2 Nanox Business Overview
11.11.3 Nanox AI-Enabled Imaging Modalities Introduction
11.11.4 Nanox Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.11.5 Nanox Recent Developments
11.12 Butterfly Network, Inc.
11.12.1 Butterfly Network, Inc. Company Details
11.12.2 Butterfly Network, Inc. Business Overview
11.12.3 Butterfly Network, Inc. AI-Enabled Imaging Modalities Introduction
11.12.4 Butterfly Network, Inc. Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.12.5 Butterfly Network, Inc. Recent Developments
11.13 Hyperfine
11.13.1 Hyperfine Company Details
11.13.2 Hyperfine Business Overview
11.13.3 Hyperfine AI-Enabled Imaging Modalities Introduction
11.13.4 Hyperfine Revenue in AI-Enabled Imaging Modalities Business (2018-2023)
11.13.5 Hyperfine Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon, Inc.
Agfa
Hologic
Fujifilm
Konica Minolta, Inc.
United Health Imaging
Exo
Nanox
Butterfly Network, Inc.
Hyperfine
听
听
*If Applicable.
